ESPEN Congress Leipzig 2013

Size: px
Start display at page:

Download "ESPEN Congress Leipzig 2013"

Transcription

1 ESPEN Congress Leipzig 2013 Nutrition and cancer: impact on outcome Survival, quality of life, reduced toxicity: what can be achieved in cancer patients? M.A.E. van Bokhorst - de van der Schueren (NL)

2 Survival, reduced toxicity, quality of life What can be achieved in cancer patients? Marian A.E. van Bokhorst de van der Schueren, RD PhD

3 3 Contents Overview of studies associating malnutrition to outcome measures Overview of studies investigating the effects of nutritional intervention on outcome measures by treatment modality Summary, conclusions and recommendations

4 % Patients With Weight Loss Nutritional status of patients with cancer; frequency and severity of weight loss 0% Colon Prostate Lung small cell Lung non - small cell Pancreas Non - measurable gastric Measurable gastric - 20% 26% 28% 23% 18% 29% 21% 20% - 40% - 60% 14% 14 % 18% 10% 20% 14% Weight loss in previous 6 months 21% 15% 28% 26% 32% 30% 29% 38% - 80% 0% 5% 5% 10% >10%. DeWys Am J Med 1980;

5 Prognostic impact of weight loss Shorter median survival time Trend towards diminished chemotherapy response rates Decreasing performance status DeWys Am J Med 1980;

6 Weight loss, toxicity, QoL, survival 1555 GI cancer patients undergoing chemotherapy Retrospective study Relation to Toxicity: stomatitis, plantar palmar syndrome QoL Performance status Failure free and overall survival Andreyev et al Eur J Cancer 34:

7 QOL score Weight loss and quality of life QOL score (EORTC QLQ C-30) * * * 25 0 Esophageal Gastric Pancreatic Colorectal Type of cancer Patients with weight loss Patients without weight loss *P< 0.01 for each comparison P< for all groups combined Andreyev et al Eur J Cancer 34:

8 Effect of weight loss on outcomes : chemotherapy in GI cancer Patients received 1 month less chemo Weight loss was associated with decreased response rate (p< 0.006), quality of life (p<0.0001) and performance status (p<0.0001) Weight loss associated with shorter survival duration (p<0.0001) Those who stopped losing weight had better overall survival => rationale for attempting randomised nutritional intervention trials Andreyev HJN et al Eur Journal Cancer 1998,34:503-9

9 Malnutrition and poor QoL QoL score (EORTC QLQ-C30) Strong relation between QoL and weight loss, independent of tumour stage, treatment Nourissat Eur J Cancer 2008: Tumour localisation Tumour stage at diagnosis < 10% WL 10% WL NS Local P<0.001 Locoregional P<0.001 Metastatic P=0.002 Chemotherapy Yes P<0.001 No P=

10 How nutritional status affects outcome Marin Caro Curr Opin Clin Nutr Metab Care 10:

11 Malnutrition and toxicity 100 % Time (weeks) Xerostomia Mucositis Dysphagia Malnutrition Langius. Radiother Oncol Oct;97(1):

12 Impact of anorexia and weight loss on mortality Total Anorexia No WL (A) WL > 10% No anorexia (WL) No WL No anorexia (N) Cancer Anorexia Cachexia Syndrome 484 (100%) 163 (34%) 46 (10%) 125 (26%) 150 (30%) Lasheen W & Walsh D. Support Care Cancer 2010; 10:

13 Observational studies There is (enough) evidence that a diminished nutritional status is associated with impaired quality of life, increased adverse events and even higher mortality

14 Evidence for effects of nutritional interventions? Treatment modality radiotherapy chemotherapy surgery Form of nutritional intervention 14

15 Relevant outcome measures? Weight stabilisation Maintenance / gain in fat free mass Improved intake in energy and protein Reduced toxicity Less delay in treatment / less dose adaptations Reduction of postoperative complications Improved (overall / recurrence free) survival Quality of life Improved (Karnofksy) performance status (KPS)

16 Radiotherapy (H&N), effects of nutritional intervention Systematic review including 12 trials Counseling vs no-counseling or counseling by a nurse : Positive effects: intake, nutritional status, QoL Inconsisent: complications ONS vs no supplements: Positive effects: intake. To be further studied: QoL?? (1 positive study) Langius. Clin Nutr 2013, in press

17 Protein intake in grams Benefits of Nutritional Counselling on Protein Intake During RTh (colon) NC ONS NIL RTh start end Ravasco P et al, JCO 2005; 23:

18 Long term follow-up NC ONS NIL Survival Late toxicity symptoms Ravasco P. Am J Clin Nutr 2012;96:

19 Nutritional counseling 2 Meta-analyses: Halfdanarson: J Support Oncol 2008;6: : Dietary counseling Outcome: QOL Trend towards increasing QoL Baldwin: J Natl Cancer Inst 2012;104: Dietary counseling, or ONS, or both Outcome: nutritional and clinical outcomes and QoL Improvement in weight and in energy intake Improvement in some aspects of QoL No effects on mortality

20 Chemotherapy Many studies have shown associations between weight loss and adverse events, dose reduction, severity of toxicity symptoms But only few studies have addressed effects of nutritional intervention: results not convincing

21 Chemotherapy Dintinjana, Coll Antropol Sep;32(3):737-40: Historical control group, n=173 Nutrition intervention (+ megestrol acetate), n=215 Temporary stop of weight loss (esp. in those receiving megestrol acetate); no influence on course of disease, KPS Baldwin, J Hum Nutr Diet 2011, Oct;24(5):431-4: 4 different nutritional interventions during 6 weeks, starting at beginning of chemotherapy (n=358) No differences in 1 y survival, weight, or QoL Study stopped early because of lack of effects

22 Upper GI Surgery Meta-analysis including 11 trials, > 1000 patients, immunonutrition (IN):,arg, n3-fa, RNA, glu, vs standard diet postoperative infections non-infection complications length of hospital stay in upper GI surgical oncology patients Either with preoperative, postoperative or combined preoperative and postoperative use Irrespective of nutritional status, iso-nitrogenous regimen. What about clinical practice? Changing operative techniques > laparascopic. Effects? Zhang, Surgical Oncology 21 (2012) e87-e95

23 Head and neck surgery Much less convincing evidence Systematic review including 14 trials, > 800 patients, IN (mostly: arginine) vs polymeric feeds A possible reduction in the length of postoperative hospital? but the reason for this reduction is not clear Some studies showed statistical differences with less complications / decrease of fistula formation in arginine enhanced group One study studied long term survival Casas Rodera, Nutr Hosp. 2012;27(3):

24 Survival Arginine.. Polymeric feed Buijs, Am J Clin Nutr 2010; 92 (5):

25 Multiple sites EN, TPN, separate nutrients

26

27 In conclusion (1) Weight loss has been associated with poor outcomes in multiple studies Nutritional intervention has been shown to maintain weight, to improve intake, and, maybe, to influence some aspects of QoL Most evidence available for RTh, however few studies Studies in patients undergoing chemotherapy are scarce Upper GI surgery: immunonutrition

28 In conclusion (2) Need for studies investigating relevant outcomes: Toxicity Treatment delay Complications Survival We know what to do!

29

Nutritional Counselling, cancer Outcome and Quality of Life!

Nutritional Counselling, cancer Outcome and Quality of Life! Nutritional Counselling, cancer Outcome and Quality of Life! Paula Ravasco p.ravasco@fm.ul.pt Unit of Nutrition and Metabolism, Institute of Molecular Medicine Faculty of Medicine of the University of

More information

* P< 0.01 for each comparison; P< for all groups combined. ! During anticancer therapy, involuntary weight loss is

* P< 0.01 for each comparison; P< for all groups combined. ! During anticancer therapy, involuntary weight loss is COMMON Head and Neck Esophagus Stomach Pancreas Lung INTERMEDIATE Colorectal Ovarian Lymphoma UNCOMMON Breast Prostate Leukemia M Schattner, MSKCC, ASPEN 2008 Retrospective review of QOL (EORTC QLQ C-30)

More information

Diet what helps? Lindsey Allan Macmillan Oncology Dietitian Royal Surrey County Hospital, Guildford

Diet what helps? Lindsey Allan Macmillan Oncology Dietitian Royal Surrey County Hospital, Guildford Diet what helps? Lindsey Allan Macmillan Oncology Dietitian Royal Surrey County Hospital, Guildford Diet and cancer Diet and cancer Nutrition research Lack of funding RCTs Low quality Small sample sizes

More information

The impact of malnutrition and overnutrition on cancer outcomes Alessandro Laviano, MD

The impact of malnutrition and overnutrition on cancer outcomes Alessandro Laviano, MD ESMO Symposium Nutrition and Cancer (Zurich, 20-21 March 2009) The impact of malnutrition and overnutrition on cancer outcomes Alessandro Laviano, MD alessandro.laviano@uniroma1.it OUTLINE Malnutrition

More information

Nutritional care during and after chemo- and radiotherapy. M. Larsson (SE)

Nutritional care during and after chemo- and radiotherapy. M. Larsson (SE) ESPEN Congress Leipzig 2013 Nursing Session Nutritional care during and after chemo- and radiotherapy M. Larsson (SE) Nutritional care during and after chemo- and radiotherapy Maria Larsson, RN, PhD Nurse

More information

Cancer Anorexia Cachexia Syndrome

Cancer Anorexia Cachexia Syndrome Cancer Anorexia Cachexia Syndrome John Mulder, MD Chief Medical Consultant for Hospice and Palliative Care Holland Home Medical Director, Trillium Institute Grand Rapids, MI Cancer Cachexia - Definitions

More information

nutrition and cancer Weight loss and Quality of Life (QoL) Nutrition and QoL wound healing Surgery & RT hospital stay rehospitalisations Malabsorption

nutrition and cancer Weight loss and Quality of Life (QoL) Nutrition and QoL wound healing Surgery & RT hospital stay rehospitalisations Malabsorption The impact of nutrition intervention in cancer patients Paula Ravasco Unidade de Nutrição e Metabolismo Instituto de Medicina Molecular Faculdade de Medicina da Universidade de Lisboa deterioration is

More information

Nutritional requirements in advanced cancer patients

Nutritional requirements in advanced cancer patients Nutritional requirements in advanced cancer patients Paula Ravasco p.ravasco@fmedicina.ulisboa.pt Laboratory of Nutrition Faculty of Medicine of the University of Lisbon Medical School of Lisbon Portugal

More information

Nutrition support for sarcopenia in cancer patients

Nutrition support for sarcopenia in cancer patients Nutrition support for sarcopenia in cancer patients Kalliopi Anna Poulia, RD, MMedSci, PhD Clinical Nutritionist-Dietitian, Laiko General Hospital of Athens Vice President of the Hellenic Dietetic Association

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Abdominal pain, enteral therapy in acute pancreatitis and, 812 Abscess(es), pancreatic, nutritional support for, 814 815 Acute Physiology and

More information

ESPEN Congress Copenhagen 2016

ESPEN Congress Copenhagen 2016 ESPEN Congress Copenhagen 2016 PARENTERAL NUTRITION IN ONCOLOGY PATIENTS INDICATIONS AND CONTRAINDICATIONS F. Bozzetti (IT) Parenteral nutrition in oncology patients indications and contraindications Federico

More information

The use of omega-3 fatty acids in the management of cancer cachexia. Rhys White Principal Oncology Dietitian Guys and St Thomas NHS Foundation Trust

The use of omega-3 fatty acids in the management of cancer cachexia. Rhys White Principal Oncology Dietitian Guys and St Thomas NHS Foundation Trust The use of omega-3 fatty acids in the management of cancer cachexia Rhys White Principal Oncology Dietitian Guys and St Thomas NHS Foundation Trust Overview Cancer cachexia Clinical features Pathogenesis

More information

Subject Index. rationale for supplementation in cancer patients 260, 273 surgical cancer patient supplementation

Subject Index. rationale for supplementation in cancer patients 260, 273 surgical cancer patient supplementation Acute-phase response, cytokine mediation in cachexia 157, 158 ß 2 -Adrenergic agonist, effects on rat tumor models 264 Alcohol breast cancer studies 107, 108, 111, 112, 116 ß-carotene interactions 53 lung

More information

Nutrition to improve patients outcomes

Nutrition to improve patients outcomes Nutrition to improve patients outcomes Dietary Counselling: a Simple but Effective way to improve Cancer Outcomes Paula Ravasco p.ravasco@fm.ul.pt Unit of Nutrition and Metabolism, Institute of Molecular

More information

ESPEN guidelines: Nutritional interventions in advanced cancer care. -An overview and pending research questions

ESPEN guidelines: Nutritional interventions in advanced cancer care. -An overview and pending research questions 1 ESPEN guidelines: Nutritional interventions in advanced cancer care -An overview and pending research questions Tora Skeidsvoll Solheim, MD, PhD Oslo, October 2017 2 3 Definition of cachexia Cancer cachexia

More information

Too little, too late Real World Insights on Current Practice of Home Parenteral Nutrition in Germany

Too little, too late Real World Insights on Current Practice of Home Parenteral Nutrition in Germany Too little, too late Real World Insights on Current Practice of Home Parenteral Nutrition in Germany ESMO 2018, Munich Prof. Dr. med. Ingolf Schiefke Gastroenterology and Hepatology Klinikum St. Georg

More information

Stellenwert der prä- und postoperativen Sicht des Chirurgen

Stellenwert der prä- und postoperativen Sicht des Chirurgen Interdisziplinäre Chirurgie Stellenwert der prä- und postoperativen Ernährung Sicht des Chirurgen Kantonsspital Luzern 24.11.2005 Prof. L. Krähenbühl Chirurgische Klinik Hôpital Cantonal Fribourg Problems

More information

ESPEN Congress Geneva 2014 LLL LIVE COURSE: NUTRITIONAL SUPPORT IN CANCER. Mechanisms and clinical features of cachexia P.

ESPEN Congress Geneva 2014 LLL LIVE COURSE: NUTRITIONAL SUPPORT IN CANCER. Mechanisms and clinical features of cachexia P. ESPEN Congress Geneva 2014 LLL LIVE COURSE: NUTRITIONAL SUPPORT IN CANCER Mechanisms and clinical features of cachexia P. Ravasco (PT) Mechanisms and clinical features of nutritional patterns in cancer

More information

Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: A systematic review

Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: A systematic review INTERNATIONAL JOURNAL OF ONCOLOGY 28: 5-23, 2006 5 Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: A systematic review M. ELIA 1, M.A.E. VAN

More information

Multimodality therapy for esophageal cancer: should nutritional support be included? Federico Bozzetti. ESMO SYMPOSIUM Zurich March 2009

Multimodality therapy for esophageal cancer: should nutritional support be included? Federico Bozzetti. ESMO SYMPOSIUM Zurich March 2009 Multimodality therapy for esophageal cancer: should nutritional support be included? Federico Bozzetti ESMO SYMPOSIUM Zurich 20-21 March 2009 TOPICS Nutritional status: obesity and weight loss (WL) Metabolic

More information

La Nutrizione Artificiale dall ospedale al domicilio

La Nutrizione Artificiale dall ospedale al domicilio La Nutrizione Artificiale dall ospedale al domicilio Federico Bozzetti Cagliari 25-26 Marzo 2009 Nutrition of the cancer patient Prevalence of malnutrition Effect of malnutrition on the outcome: - survival

More information

Medical Oncologist/Palliative care Physician Director Cancer Rehabilitation Program Division of Oncology Royal Victoria Hospital MONTREAL

Medical Oncologist/Palliative care Physician Director Cancer Rehabilitation Program Division of Oncology Royal Victoria Hospital MONTREAL Eating Drinking, Living after Curative Therapy for Esophageal cancer Dr. Martin Chasen Medical Oncologist/Palliative care Physician Director Cancer Rehabilitation Program Division of Oncology Royal Victoria

More information

The evidence-based nutritional support of the oncologic patient. Federico Bozzetti Faculty of Medicine, University of Milan, Italy

The evidence-based nutritional support of the oncologic patient. Federico Bozzetti Faculty of Medicine, University of Milan, Italy The evidence-based nutritional support of the oncologic patient Federico Bozzetti Faculty of Medicine, University of Milan, Italy TOPICS Rationale for the nutritional support the evidence from RCT the

More information

A prospective analysis of factors that influence weight loss in patients undergoing radiotherapy

A prospective analysis of factors that influence weight loss in patients undergoing radiotherapy Original Article A prospective analysis of factors that influence weight loss in patients undergoing radiotherapy Jon Cacicedo 1, Francisco Casquero 1, Lorea Martinez-Indart 2, Olga del Hoyo 1, Alfonso

More information

WHEN To Initiate Parenteral Nutrition A Frequent Question With New Answers

WHEN To Initiate Parenteral Nutrition A Frequent Question With New Answers WHEN To Initiate Parenteral Nutrition A Frequent Question With New Answers Ainsley Malone, MS, RD, LD, CNSC, FAND, FASPEN Dubai International Nutrition Conference 2018 Disclosures No commercial relationship

More information

ESPEN Congress Brussels Stenting of the esophagus and small bowel. Jean-Marc Dumonceau

ESPEN Congress Brussels Stenting of the esophagus and small bowel. Jean-Marc Dumonceau ESPEN Congress Brussels 2005 Stenting of the esophagus and small bowel Jean-Marc Dumonceau Stenting of the esophagus and small bowel Jean-Marc Dumonceau, Div. of Gastroenterology Geneva, Switzerland Indication:

More information

Preoperative Quality of Life in Patients with Gastric Cancer

Preoperative Quality of Life in Patients with Gastric Cancer pissn : 2093-582X, eissn : 2093-5641 J Gastric Cancer 2015;15(2):121-126 http://dx.doi.org/10.5230/jgc.2015.15.2.121 Original Article Preoperative Quality of Life in Patients with Gastric Cancer Hyoam

More information

Veeradej Pisprasert, MD PhD

Veeradej Pisprasert, MD PhD Immunonutrition: Asian Perspectives Evidence of Immunonutrition in Asia Veeradej Pisprasert, MD PhD Division of Clinical Nutrition Department of Medicine, Khon Kaen University pveera@kku.ac.th Outline

More information

Cancer cachexia: assessment and classification. KCH Fearon University of Edinburgh Scotland

Cancer cachexia: assessment and classification. KCH Fearon University of Edinburgh Scotland Cancer cachexia: assessment and classification KCH Fearon University of Edinburgh Scotland 1 What is the cancer cachexia phenotype?...the shoulders, clavicles, chest and thighs melt away. This illness

More information

De-Escalate Trial for the Head and neck NSSG. Dr Eleanor Aynsley Consultant Clinical Oncologist

De-Escalate Trial for the Head and neck NSSG. Dr Eleanor Aynsley Consultant Clinical Oncologist De-Escalate Trial for the Head and neck NSSG Dr Eleanor Aynsley Consultant Clinical Oncologist 3 HPV+ H&N A distinct disease entity Leemans et al., Nature Reviews, 2011 4 Good news Improved response to

More information

Nutrition and Cancer. Prof. Suhad Bahijri

Nutrition and Cancer. Prof. Suhad Bahijri Nutrition and Cancer Objectives 1. Discuss current knowledge regarding nutritional prevention of cancer 2. Discuss goals for the cancer patient 3. Explain how cancer treatment affects nutritional needs

More information

Ingvar Bosaeus, MD, Sahlgrenska University Hospital, Goteborg, Sweden

Ingvar Bosaeus, MD, Sahlgrenska University Hospital, Goteborg, Sweden Cachexia in Cancer Ingvar Bosaeus, MD, Sahlgrenska University Hospital, Goteborg, Sweden Severe, progressive malnutrition and wasting often is seen in advanced cancer, with weight loss long associated

More information

Advances in gastric cancer: How to approach localised disease?

Advances in gastric cancer: How to approach localised disease? Advances in gastric cancer: How to approach localised disease? Andrés Cervantes Professor of Medicine Classical approach to localised gastric cancer Surgical resection Pathology assessment and estimation

More information

MINIMALLY INVASIVE ESOPHAGECTOMY FOR CANCER: where do we stand?

MINIMALLY INVASIVE ESOPHAGECTOMY FOR CANCER: where do we stand? MINIMALLY INVASIVE ESOPHAGECTOMY FOR CANCER: where do we stand? Ph Nafteux, MD Copenhagen, Nov 3rd 2011 Department of Thoracic Surgery, University Hospitals Leuven, Belgium W. Coosemans, H. Decaluwé, Ph.

More information

Nutritional Support in the Perioperative Period

Nutritional Support in the Perioperative Period Nutritional Support in the Perioperative Period Topic 17 Module 17.3 Nutritional Support in the Perioperative Period Ken Fearon Learning Objectives Understand the principles behind nutritional care for

More information

Demands and Perspectives of Hadron Therapy

Demands and Perspectives of Hadron Therapy Demands and Perspectives of Hadron Therapy Alexander Lin, M.D. Assistant Professor University of Pennsylvania Direction of Operations Roberts Proton Therapy Center Disclosures Teva Pharmaceuticals: Advisory

More information

Nutritional assessment & support for the upper GI cancer patient

Nutritional assessment & support for the upper GI cancer patient Nutritional assessment & support for the upper GI cancer patient Catherine Fleuret Specialist Dietitian, The Royal Marsden Outline Nutritional status & implications The role of nutrition & the dietitian

More information

Nutrition for Patients with Cancer or HIV/AIDS Chapter 22

Nutrition for Patients with Cancer or HIV/AIDS Chapter 22 Nutrition for Patients with Cancer or HIV/AIDS Chapter 22 Nutrition for Patients with Cancer or HIV/AIDS Cancer and HIV/AIDS can cause devastating weight loss and malnutrition. Nutrition therapy Cannot

More information

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type. Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic

More information

SAMO MASTERCLASS HEAD & NECK CANCER. Nicolas Mach, PD Geneva University Hospital

SAMO MASTERCLASS HEAD & NECK CANCER. Nicolas Mach, PD Geneva University Hospital SAMO MASTERCLASS HEAD & NECK CANCER Nicolas Mach, PD Geneva University Hospital Epidemiology Prevention Best treatment for localized disease Best treatment for relapsed or metastatic disease Introduction

More information

Esophageal Cancer. What is the value of performing PET scan routinely for staging of esophageal cancers

Esophageal Cancer. What is the value of performing PET scan routinely for staging of esophageal cancers Esophageal Cancer What is the value of performing PET scan routinely for staging of esophageal cancers What is the sensitivity and specificity of PET scan for metastatic lesions When should PET scan be

More information

ESPEN Congress Copenhagen 2016

ESPEN Congress Copenhagen 2016 ESPEN Congress Copenhagen 2016 ESPEN GUIDELINES SURGERY A. Weimann (DE) ESPEN Guideline Clinical Nutrition in Surgery Conflicts of interest Speaker `s honoraria: Baxter Germany Berlin Chemie B. Braun Melsungen

More information

Review on Tumour Doubling Time (DT) To review the studies that measuring the actual tumour doubling time for human cancers.

Review on Tumour Doubling Time (DT) To review the studies that measuring the actual tumour doubling time for human cancers. Review on Tumour Doubling Time (DT) Objective To review the studies that measuring the actual tumour doubling time for human cancers. Methods We searched the Medline database from January 1966 to January

More information

Effect of Nutritional Risk at Admission on the Length of Hospital Stay and Mortality in Gastrointestinal Cancer Patients

Effect of Nutritional Risk at Admission on the Length of Hospital Stay and Mortality in Gastrointestinal Cancer Patients Original Article Clin Nutr Res 2013;2:12-18 pissn 2287-3732 eissn 2287-3740 Effect of Nutritional Risk at Admission on the Length of Hospital Stay and Mortality in Gastrointestinal Cancer Patients Hosun

More information

LA NUTRIZIONE ARTIFICIALE DOMICILIARE: LUCI E OMBRE

LA NUTRIZIONE ARTIFICIALE DOMICILIARE: LUCI E OMBRE LA NUTRIZIONE ARTIFICIALE DOMICILIARE: LUCI E OMBRE PAOLO COTOGNI SC Terapia del Dolore e Cure Palliative Dipartimento di Anestesia e Rianimazione AOU Città della Salute e della Scienza Università di Torino

More information

Aspirin and Cancer Recent Developments

Aspirin and Cancer Recent Developments Recent Developments ICPV Brighton Conference 7 th September 2012 Alistair Ring Brighton and Sussex Medical School Bowel cancer death risks slashed by taking an aspirin a day. The Mirror 25 th April 2012.

More information

Pharmaconutrition in PICU. Gan Chin Seng Paediatric Intensivist UMMC

Pharmaconutrition in PICU. Gan Chin Seng Paediatric Intensivist UMMC Pharmaconutrition in PICU Gan Chin Seng Paediatric Intensivist UMMC Pharmaconutrition in Critical Care Unit Gan Chin Seng Paediatric Intensivist UMMC Definition New concept Treatment with specific nutrients

More information

Adjuvant therapy for thyroid cancer

Adjuvant therapy for thyroid cancer Carcinoma of the thyroid Adjuvant therapy for thyroid cancer John Hay Department of Radiation Oncology Vancouver Cancer Centre Department of Surgery UBC 1% of all new malignancies 0.5% in men 1.5% in women

More information

ABC of palliative care: Anorexia, cachexia, and nutrition

ABC of palliative care: Anorexia, cachexia, and nutrition BMJ 1997;315:1219-1222 (8 November) Clinical review ABC of palliative care: Anorexia, cachexia, and nutrition Eduardo Bruera Top Does the patient have... Why is the patient... Cachexia is a complex syndrome

More information

The role of chemoradiotherapy in GE junction and gastric cancer. Karin Haustermans

The role of chemoradiotherapy in GE junction and gastric cancer. Karin Haustermans The role of chemoradiotherapy in GE junction and gastric cancer Karin Haustermans Overview Postoperative chemoradiotherapy Preoperative chemoradiotherapy Palliative radiation Technical aspects Overview

More information

Neoplastic Disease KNH 406

Neoplastic Disease KNH 406 Neoplastic Disease KNH 406 Cancer Carcinogenesis - Etiology Genes may be affected by antioxidants, soy, protein, fat, kcal, alcohol Nutritional genomics study of genetic variations that cause different

More information

Gastrointestinal Feedings Post Op: What s the deal on beginning oral feedings?

Gastrointestinal Feedings Post Op: What s the deal on beginning oral feedings? Gastrointestinal Feedings Post Op: What s the deal on beginning oral feedings? Kate Willcutts, DCN, RD, CNSC University of Virginia Health System Charlottesville, VA kfw3w@virginia.edu Objectives 1. Discuss

More information

Rationale for VEGFR-targeted Therapy in RCC

Rationale for VEGFR-targeted Therapy in RCC Rationale for VEGFR-targeted Therapy in RCC EIKCS, Budapest, May 2013 Tim Eisen Tim Eisen - Disclosures Company Research Support Advisory Board Trial Management Group Honoraria Astra Zeneca + + + Astellas

More information

A new era of therapeutics for cancer cachexia. Cachexia is a continuum with 3 stages of clinical relevance

A new era of therapeutics for cancer cachexia. Cachexia is a continuum with 3 stages of clinical relevance A new era of therapeutics for cancer cachexia I. Depletion of Reserves II. Limitation of food intake III. Catabolic Drivers IV. Impact and outcomes Vickie Baracos PhD Professor and Alberta Cancer Foundation

More information

19/01/2018. Artificial nutrition at the end of life- Palliation or Purgatory?

19/01/2018. Artificial nutrition at the end of life- Palliation or Purgatory? Artificial nutrition at the end of life- Palliation or Purgatory? (When) should patients near the end of life receive artificial nutrition support? Jeremy Woodward AN - Options and principles Goals and

More information

ESPEN Congress Geneva 2014 LLL LIVE COURSE: NUTRITIONAL SUPPORT IN CANCER. Multimodal therapy of cancer cachexia K. Fearon (UK)

ESPEN Congress Geneva 2014 LLL LIVE COURSE: NUTRITIONAL SUPPORT IN CANCER. Multimodal therapy of cancer cachexia K. Fearon (UK) ESPEN Congress Geneva 2014 LLL LIVE COURSE: NUTRITIONAL SUPPORT IN CANCER Multimodal therapy of cancer cachexia K. Fearon (UK) Multimodal therapy for cancer cachexia KCH Fearon Learning objectives Understand

More information

A video demonstration of the Li s anastomosis the key part of the non-tube no fasting fast track program for resectable esophageal carcinoma

A video demonstration of the Li s anastomosis the key part of the non-tube no fasting fast track program for resectable esophageal carcinoma Surgical Technique A video demonstration of the the key part of the non-tube no fasting fast track program for resectable esophageal carcinoma Yan Zheng*, Yin Li*, Zongfei Wang, Haibo Sun, Ruixiang Zhang

More information

Jejunostomy after oesophagectomy, how and why I do it

Jejunostomy after oesophagectomy, how and why I do it Jejunostomy after oesophagectomy, how and why I do it Graeme Couper. Consultant Oesophago-gastric Surgeon, The Royal Infirmary of Edinburgh BAPEN Conference 2010 2nd & 3rd November Harrogate International

More information

Long Term Results in GIST Treatment

Long Term Results in GIST Treatment Long Term Results in GIST Treatment Dr. Laurentia Gales Prof. Dr. Rodica Anghel, Dr. Xenia Bacinschi Institute of Oncology Prof Dr Al Trestioreanu Bucharest 25 th RSRMO October 15-17 Sibiu Background Gastrointestinal

More information

Are the ESMO guidelines adapted to the elderly? D. Schrijvers, MD, PhD Ziekenhuisnetwerk Antwerpen(ZNA)-Middelheim Antwerp Belgium

Are the ESMO guidelines adapted to the elderly? D. Schrijvers, MD, PhD Ziekenhuisnetwerk Antwerpen(ZNA)-Middelheim Antwerp Belgium Are the ESMO guidelines adapted to the elderly? D. Schrijvers, MD, PhD Ziekenhuisnetwerk Antwerpen(ZNA)-Middelheim Antwerp Belgium Clinical practice guidelines Definition > Systemically developed statements

More information

Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients. Bruno Vincenzi Università Campus Bio-Medico di Roma

Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients. Bruno Vincenzi Università Campus Bio-Medico di Roma Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients Bruno Vincenzi Università Campus Bio-Medico di Roma Colorectal cancer 3 rd most common cancer worldwide Approximately

More information

Y A L E S C H O O L O F M E D I C I N E. This is a CME accredited activity. The presenters and there are no conflicts of interest.

Y A L E S C H O O L O F M E D I C I N E. This is a CME accredited activity. The presenters and there are no conflicts of interest. This is a CME accredited activity. The presenters and there are no conflicts of interest. Pain in Pancreatic Cancer More than 50% of patients with pancreatic cancer suffer from abdominal and back pain

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acetate, in pediatric surgical patients, 525 526 Acute respiratory distress syndrome (ARDS), immune-modulating nutrition in, 584 585 Aerobic

More information

ProSure. Strength to Fight and Get Back to Life. Strength to Fight and Get Back to Life D1

ProSure. Strength to Fight and Get Back to Life. Strength to Fight and Get Back to Life D1 ProSure Strength to Fight and Get Back to Life ProSure. Strength to Fight and Get Back to Life 5004 1112 166 D1 Cancer care is evolving at an incredibly fast pace, and the prognosis for a person with cancer

More information

10th anniversary of 1st validated CaPspecific

10th anniversary of 1st validated CaPspecific Quality of Life after Treatment of Localised Prostate Cancer Dr Jeremy Grummet Clinical Uro-Oncology Fellow May 28, 2008 1 Why? This is important May be viewed as soft science Until we know which treatment

More information

Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study

Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study Original Article Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study Elmer E. van Eeghen 1, Frank den Boer 2, Sandra D. Bakker 1,

More information

Enhanced Recovery Beaumont Anesthesiology

Enhanced Recovery Beaumont Anesthesiology Enhanced Recovery Preoperative Fasting & Carbohydrates Roy Soto, M.D. Professor of Anesthesiology & Residency Director, Beaumont Health System July 2014 Preoperative Fasting Are all patients the same?

More information

ABSTRACT. Keywords: Chemotherapy induced anaemia, gastrointestinal cancers, India.

ABSTRACT. Keywords: Chemotherapy induced anaemia, gastrointestinal cancers, India. An Open Labeled Two Arm Study to Evaluate the Feasibility, Quality of Life, Safety and Efficacy of Darbepoetin as Compared to Erythropoietin Inpatients with Chemotherapy Induced Anemia in Patients with

More information

Adjuvant and neoadjuvant chemotherapy for rectal cancer: Expensive but little gain

Adjuvant and neoadjuvant chemotherapy for rectal cancer: Expensive but little gain Adjuvant and neoadjuvant chemotherapy for rectal cancer: Expensive but little gain Outline The problem Adjuvant therapy Neoadjuvant therapy Options Conclusion The problem 30 years ago: Local recurrence

More information

National Cancer Registration and Analysis Service Short Report: Chemotherapy, Radiotherapy and Surgical Tumour Resections in England: (V2)

National Cancer Registration and Analysis Service Short Report: Chemotherapy, Radiotherapy and Surgical Tumour Resections in England: (V2) National Cancer Registration and Analysis Service Short Report: Chemotherapy, Radiotherapy and Surgical Tumour Resections in England: 13-14 (V2) Produced as part of the Cancer Research UK - Public Health

More information

ESPEN Congress Madrid 2018

ESPEN Congress Madrid 2018 ESPEN Congress Madrid 2018 The Role Of Obesity In Cancer Survival And Cancer Recurrence Obesity As A Risk Factor For Cancer P. Ravasco (PT) Obesity as a risk factor for Cancer Paula Ravasco, Nutric, MD,

More information

Current concepts in Critical Care Nutrition

Current concepts in Critical Care Nutrition Current concepts in Critical Care Nutrition Dr.N.Ramakrishnan AB (Int Med), AB (Crit Care), MMM, FACP, FCCP, FCCM Director, Critical Care Services Apollo Hospitals, Chennai Objectives Why? Enteral or Parenteral

More information

Colon Cancer Liver Metastases: Liver-Directed Therapy

Colon Cancer Liver Metastases: Liver-Directed Therapy Colon Cancer Liver Metastases: Liver-Directed Therapy Shishir K. Maithel, MD FACS Assistant Professor of Surgery Division of Surgical Oncology Winship Cancer Institute Emory University August 10, 2014

More information

Douglas G. Adler MD. ACG Regional Postgraduate Course - Nashville, TN Copyright 2013 American College of Gastroenterology

Douglas G. Adler MD. ACG Regional Postgraduate Course - Nashville, TN Copyright 2013 American College of Gastroenterology Enteral Stents 2013: State of the Art Douglas G. Adler MD Associate Professor of Medicine Director of Therapeutic Endoscopy University of Utah School of Medicine Huntsman Cancer Center Esophageal Stents

More information

Minimally Invasive Esophagectomy- Valuable. Jayer Chung, MD University of Colorado Health Sciences Center December 11, 2006

Minimally Invasive Esophagectomy- Valuable. Jayer Chung, MD University of Colorado Health Sciences Center December 11, 2006 Minimally Invasive Esophagectomy- Valuable Jayer Chung, MD University of Colorado Health Sciences Center December 11, 2006 Overview Esophageal carcinoma What is minimally invasive esophagectomy (MIE)?

More information

2. Review of Literature:

2. Review of Literature: 2. Review of Literature: Cancer of the esophagus or head and neck can be particularly debilitating because it affects the critical functions of speech, swallowing, and breathing, as well as a patient s

More information

Neodjuvant chemotherapy

Neodjuvant chemotherapy Neodjuvant chemotherapy Dr Robert Huddart Senior Lecturer and Honorary Consultant in Clinical Oncology Royal Marsden Hospital and Institute of Cancer Research Why consider neo-adjuvant chemotherapy? Loco-regional

More information

ESPEN Congress Geneva 2014 NUTRITION AT EXTREMES: THE UNLIKELY BENEFITS OF STARVATION

ESPEN Congress Geneva 2014 NUTRITION AT EXTREMES: THE UNLIKELY BENEFITS OF STARVATION ESPEN Congress Geneva 2014 NUTRITION AT EXTREMES: THE UNLIKELY BENEFITS OF STARVATION A calorie is not a calorie: caloric restriction vs modulation of diet composition? F. Bozzetti (IT) ESPEN 2014 A calorie

More information

3/8/2014. Case Presentation. Primary Treatment of Anal Cancer. Anatomy. Overview. March 6, 2014

3/8/2014. Case Presentation. Primary Treatment of Anal Cancer. Anatomy. Overview. March 6, 2014 Case Presentation Primary Treatment of Anal Cancer 65 year old female presents with perianal pain, lower GI bleeding, and anemia with Hb of 7. On exam 6 cm mass protruding through the anus with bulky R

More information

D.A. DE LUIS, O. IZAOLA, M.C. TERROBA, L. CUELLAR, M. VENTOSA, T. MARTIN

D.A. DE LUIS, O. IZAOLA, M.C. TERROBA, L. CUELLAR, M. VENTOSA, T. MARTIN European Review for Medical and Pharmacological Sciences Effect of three different doses of arginine enhanced enteral nutrition on nutritional status and outcomes in well nourished postsurgical cancer

More information

Malnutrition: An independent Risk Factor for Postoperative Complications

Malnutrition: An independent Risk Factor for Postoperative Complications Malnutrition: An independent Risk Factor for Postoperative Complications Bryan P. Hooks, D.O. University of Pittsburgh-Horizon June 24, 2017 Orthopedic Surgeon-Adult Reconstruction Disclosures: None Objectives:

More information

Case 1 Metastatic Pancreatic Adenocarcinoma: What Therapy Should I Select First?

Case 1 Metastatic Pancreatic Adenocarcinoma: What Therapy Should I Select First? Case 1 Metastatic Pancreatic Adenocarcinoma: What Therapy Should I Select First? Marc Peeters, MD, PhD Head of the Oncology Department Antwerp University Hospital Antwerp, Belgium marc.peeters@uza.be 71-year-old

More information

Developing your Integrative Self-Care Plan

Developing your Integrative Self-Care Plan Developing your Integrative Self-Care Plan Erin Sweet ND, MPH, FABNO Assistant Research Scientist Bastyr University [PRESENTER PHOTO] Naturopathic Oncology Red Cedar Wellness Center & Orion Center for

More information

Role of Prophylactic Cranial Irradiation in Small Cell Lung Cancer

Role of Prophylactic Cranial Irradiation in Small Cell Lung Cancer Role of Prophylactic Cranial Irradiation in Small Cell Lung Cancer Kazi S. Manir MD,DNB,ECMO,PDCR Clinical Tutor Department of Radiotherapy R. G. Kar Medical College and Hospital, Kolkata SCLC 15% of lung

More information

Practice teaching course on head and neck cancer management

Practice teaching course on head and neck cancer management 28-29 October 2016 - Saint-Priest en Jarez, France Practice teaching course on head and neck cancer management IMPROVING THE PATIENT S LIFE THROUGH MEDICAL EDUCATION www.excemed.org Nicolas Magné France

More information

Nutrition care plan for surgical patients. Objectives

Nutrition care plan for surgical patients. Objectives Slide 1 Nutrition care plan for surgical patients Surgical Nutrition Training Module Level 1 Philippine Society of General Surgeons Committee on Surgical Training In this session we will discuss the most

More information

Radiotherapy for rectal cancer. Karin Haustermans Department of Radiation Oncology

Radiotherapy for rectal cancer. Karin Haustermans Department of Radiation Oncology Radiotherapy for rectal cancer Karin Haustermans Department of Radiation Oncology O U T L I N E RT with TME surgery? Neoadjuvant or adjuvant RT? 5 x 5 Gy or long-course CRT? RT with new drugs? Selection

More information

HN advanced cancer. Surgical resection, with or without adjuvant radiotherapy, provides the highest likelihood for successful salvage but

HN advanced cancer. Surgical resection, with or without adjuvant radiotherapy, provides the highest likelihood for successful salvage but HN advanced cancer Locoregional recurrences clinical problem Surgical resection, with or without adjuvant radiotherapy, provides the highest likelihood for successful salvage but Many patients present

More information

A randomized double-blind clinical trial with two different doses of arginine enhanced enteral nutrition in postsurgical cancer patients

A randomized double-blind clinical trial with two different doses of arginine enhanced enteral nutrition in postsurgical cancer patients European Review for Medical and Pharmacological Sciences 2010; 14: 941-945 A randomized double-blind clinical trial with two different doses of arginine enhanced enteral nutrition in postsurgical cancer

More information

DGEM Guidelines Enteral Nutrition

DGEM Guidelines Enteral Nutrition ESPEN Congress Cannes 2003 Organised by the Israel Society for Clinical Nutrition Education and Clinical Practice Programme Session: Nutritional Guidelines: ESPEN and other Societies German Society of

More information

PATHOLOGIC FACTORS PROGNOSTIC OF SURVIVAL IN PATIENTS WITH GI TRACT AND PANCREATIC CARCINOMA TREATED WITH NEOADJUVANT THERAPY

PATHOLOGIC FACTORS PROGNOSTIC OF SURVIVAL IN PATIENTS WITH GI TRACT AND PANCREATIC CARCINOMA TREATED WITH NEOADJUVANT THERAPY PATHOLOGIC FACTORS PROGNOSTIC OF SURVIVAL IN PATIENTS WITH GI TRACT AND PANCREATIC CARCINOMA TREATED WITH NEOADJUVANT THERAPY Jeannelyn S. Estrella, MD Department of Pathology The UT MD Anderson Cancer

More information

Are we making progress? Marked reduction in operative morbidity and mortality

Are we making progress? Marked reduction in operative morbidity and mortality Are we making progress? Surgical Progress Marked reduction in operative morbidity and mortality Introduction of Minimal-Access approaches for complex esophageal cancer resections Significantly better functional

More information

PhilSPEN Online Journal of Parenteral and Enteral Nutrition. Issue January- June

PhilSPEN Online Journal of Parenteral and Enteral Nutrition. Issue January- June Title: Nutrition care of ICU patients upon discharge from hospital to community (Delivered at the Abbott Nutrition Night, PENSA in Taiwan, October 2011) Authors: Eliza Mei Francisco MD and Luisito O. Llido

More information

Pan Arab Journal of Oncology

Pan Arab Journal of Oncology Pan Arab Journal of Oncology Original Article Retrospective Analysis of Clinicopathologic and Management Aspects of Soft Tissue Sarcoma Tarek Hussein Kamel, Azza Mohamed Adel, Reham Mohamed Faheim, Rana

More information

Perioperative versus adjuvant management of gastric cancer, update 2013

Perioperative versus adjuvant management of gastric cancer, update 2013 Perioperative versus adjuvant management of gastric cancer, update 2013 Cornelis J.H. van de Velde, MD, PhD,FRCPS and FACS,Hon. Professor of Surgery President ECCO - the European Cancer Organization Past-President

More information

Pelvic palliative radiotherapy for gynecological cancers present state of knowledge and pending research questions to answer

Pelvic palliative radiotherapy for gynecological cancers present state of knowledge and pending research questions to answer Pelvic palliative radiotherapy for gynecological cancers present state of knowledge and pending research questions to answer Esten S. Nakken MD PhD Division of Cancer Medicine Oslo University Hospital

More information

REVIEW. M. A. E. de van der Schueren 1,2 *, A. Laviano 3, H. Blanchard 4, M. Jourdan 4, J. Arends 5 & V. E. Baracos 6

REVIEW. M. A. E. de van der Schueren 1,2 *, A. Laviano 3, H. Blanchard 4, M. Jourdan 4, J. Arends 5 & V. E. Baracos 6 Annals of Oncology 29: 1141 1153, 2018 doi:10.1093/annonc/mdy114 Published online 18 April 2018 REVIEW Systematic review and meta-analysis of the evidence for oral nutritional intervention on nutritional

More information

Cetuximab/cisplatin and radiotherapy in HNSCC: is there a favorite choice?

Cetuximab/cisplatin and radiotherapy in HNSCC: is there a favorite choice? Cent. Eur. J. Med. 9(2) 2014 279-284 DOI: 10.2478/s11536-013-0154-9 Central European Journal of Medicine Cetuximab/cisplatin and radiotherapy in HNSCC: is there a favorite choice? Jacopo Giuliani* 1, Marina

More information

17. Oesophagus. Upper gastrointestinal cancer

17. Oesophagus. Upper gastrointestinal cancer 110 17. Upper gastrointestinal cancer Oesophagus Radical treatment For patients with localised disease, the standard curative approach to treatment is either surgery + perioperative chemotherapy, surgery

More information

PROTEIN ANABOLIC RESISTANCE IN CANCER

PROTEIN ANABOLIC RESISTANCE IN CANCER PROTEIN ANABOLIC RESISTANCE IN CANCER Dr. Barbara van der Meij CRICOS CODE 00017B CONTENTS Obesity and body composition Metabolic alterations in cancer Protein anabolic resistance Implications for clinical

More information